A New Era of
Drug Development
We connect leading researchers to investors by turning intellectual property and data into liquid assets.
How our platform connects biopharma research to funding
Academic Researchers
Often see their valuable early-stage research go undeveloped and discovery of breakthrough therapeutics slowed down
Have very limited access to investors outside of big pharma and limited knowledge about opportunities in web3
The Molecule Platform
Brings liquidity to a formerly illiquid asset class by tokenizing early stage IP and its associated research projects
Lowers risk through fractionalizing of IP, support in due diligence and creation of special purpose vehicles
Biopharma Investors
Require support with due diligence and pricing of intellectual property
Want to hedge risk through building portfolios of investments in areas of interest.
Researchers
Get Access To Funding For Your Therapeutics Research.
List your research projects and engage with potential investors to secure funding for your drug development efforts. Get in touch to learn more about new opportunities for direct investment in your data, work and IP.
List Your ProjectInvestors
Fund the Next Therapeutics Breakthrough in an Area of your Interest
Find pre-screened projects and IP attached to NFTs, liquid and transferable. Discover opportunities on our platform and invest in biopharma researchers and their work. Draw from our experience in the creation of a dedicated DAO for your area of interest.
See Opportunities
We believe the future of life science research is driven by open, liquid markets for intellectual property powered by web3 technology.
Launching the first biopharma DAO powered by Molecule
VitaDAO is a decentralized organization funding early stage longevity research. Molecule supports the cause by providing access to suitable tokenized projects. We invite your to learn more about this exciting opportunity and support the fight against age-related diseases and expand human health-span.
Learn More
Watch the AMA with Aubrey de Grey and Vitalik Buterin hosted by VitaDAO
The Molecule Tech Stack
Our long-term goal is to decentralize ownership, financing and governance processes within drug development. To achieve this, we are pioneering approaches to fractional and decentralized IP and data ownership.
Backed By Pioneers & Visionaries
